ArticleArthritis research & therapy2004

The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes.

Gaby Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.